Skip to main content
. 2016 Jun 29;6:28653. doi: 10.1038/srep28653

Figure 4. Effects of T-type and L-type VGCC inhibitors on GDF-15-induced enhancement of mEPSC frequency and glutamate release.

Figure 4

(A) Representative recordings and bar graph showing effect of T-type VGCC blocker NiCl2 on GDF-15-induced increase in mEPSC frequency. (B) Representative recordings and bar graph showing effect of T-type VGCC blocker mibefradil on GDF-15-induced increases in mEPSC frequency and glutamate release. (C) Representative recordings and bar graph showing the effects of T-type VGCC blocker TTA-P2 on the GDF-15-induced increase in mEPSC frequency and glutamate release. (D) Representative recordings and bar graph showing effect of L-type VGCC blocker nifedipine on GDF-15-induced increases in mEPSC frequency and glutamate release. Results are shown as means ± SEM. *p < 0.05 compared with corresponding control (without GDF-15) determined by unpaired Student’s t-test.